Oxidant mechanisms in toxic acute renal failure

Drug Metabolism Reviews

Volumn 31, Issue 4, 1999, Pages 971-997

  Baliga, Radhakrishna ^a   Ueda, Norishi ^b,c   Walker, Patrick D ^b   Shah, Sudhir V ^b,c,d  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; ALPHA TOCOPHEROL; ANTIOXIDANT; BENZOIC ACID; CIMETIDINE; CISPLATIN; CYCLOSPORIN; CYTOCHROME P450; DEFEROXAMINE; GENTAMICIN; GLUTATHIONE; GLYCEROL; HEME OXYGENASE; HYDROGEN PEROXIDE; IRON; IRON CHELATING AGENT; OXYGEN RADICAL; PIPERONYL BUTOXIDE; RANITIDINE; SCAVENGER; SELENIUM;

ACUTE KIDNEY FAILURE; ARTICLE; HUMAN; KIDNEY CORTEX; MITOCHONDRION; NEPHROTOXICITY; OXIDATION; PATHOGENESIS; PEROXIDATION; RHABDOMYOLYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CISPLATIN; CRYOPROTECTIVE AGENTS; CYCLOSPORINE; GENTAMICINS; GLYCEROL; HYDROGEN PEROXIDE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, ACUTE; OXIDANTS; RATS; REACTIVE OXYGEN SPECIES;

EID: 0032725720     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101947     Document Type: Article

References (84)

1. J. M. McCord and I. Fridovich, Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), J. Biol. Chem., 244, 6049-6055 (1969).
2. J. M. McCord, Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase, Science, 185, 529-531 (1974).
3. J. M. McCord, Oxygen-derived free radicals in postischemic tissue injury, N. Engl. J. Med., 312, 159-163 (1985).
4. J. C. Fantone and P. A. Ward, Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions, Am. J. Pathol., 107, 397-418 (1982).
5. S. J. Weiss, Oxygen, ischemia and inflammation, Acta Physiol. Scand., 126, 9-37 (1986).
6. L. Baud and R. Ardaillou, Reactive oxygen species: Production and role in the kidney, Am. J. Physiol., 251, F765-F776 (1986).
7. B. A. Freeman and J. D. Crapo, Free radicals and tissue injury, Lab. Invest., 47, 412-426 (1982).
8. B. Halliwell and J. M. C. Gutteridge, Role of free radicals and catalytic metal ions in human disease: An overview, Methods Enzymol., 186, 1-85 (1990).
9. C. E. Cross, B. Halliwell, E. T. Borish, W. A. Pryor, B. N. Ames, R. L. Saul, J. M. McCord, and D. Harman, Oxygen radicals and human disease, Ann. Intern. Med., 107, 526-545 (1987).
10. J. M. McCord and I. Fridovich, The biology and pathology of oxygen radicals, Ann. Intern. Med., 89, 122-127 (1978).
11. I. Fridovich, The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity; superoxide dismutases provide an important defense, Science, 201, 875-880 (1978).
12. H. D. Humes and J. M. Weinberg, Toxic nephropathies, in The Kidney (B. M. Brenner and J. Rector, eds.), W. B. Saunders, Philadelphia, 1986, pp. 1491-1532.
13. P. D. Walker and S. V. Shah, Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria, Am. J. Physiol., 253, C495-C499 (1987).
14. C. L. Yang, X. H. Du, and Y. X. Man, Renal cortical mitochondria are the source of oxygen free radicals enhanced by gentamicin, Renal Failure, 17, 21-26 (1995).
15. B. R. Guidet and S. V. Shah, In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli, Am. J. Physiol., 256, F158-F164 (1989).
16. E. Margoliash, A. Novogrodsky, and A. Schejter, Irreversible reaction of 3-amino-1:2:4-triazole and related inhibitors with the protein of catalase, Biochem. J., 74, 339-348 (1960).
17. T. R. Tephly, G. J. Mannering, and J. Parks, Studies on the mechanism of inhibition of liver and erthyrocyte catalase activity by 3-amino-1,2,4-triazole (AT), J. Pharmacol. Exp. Therap., 134, 77-82 (1961).
18. T. Yusa, J. S. Beckman, J. D. Crapo, and B. A. Freeman, Hyperoxia increases H2O2 production by brain in vivo, J. Appl. Physiol., 63, 353-358 (1987).
19. N. Ueda, B. Guidet, and S. V. Shah, Gentamicin-induced mobilization of iron from renal cortical mitochondria, Am. J. Physiol., 265, F435-F439 (1993).
20. E. M. Priuska and J. Schacht, Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex, Biochem. Pharmacol., 50, 1749-1752 (1995).
21. P. D. Walker and S. V. Shah, Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats, J. Clin. Invest., 81, 334-341 (1988).
22. T. Nakajima, A. Hishida, and A. Kato, Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats, Am. J. Physiol., 266, F425-F431 (1994).
23. L. S. Ramsammy, C. Josepovitz, K. Y. Ling, B. P. Lane, and G. J. Kaloyanides, Effects of diphenyl-phenylenediamine on gentamicin-induced lipid peroxidation and toxicity in rat renal cortex, J. Pharmacol. Exp. Therap., 255, 83-88 (1986).
24. O. Ademuyiwa, E. O. Ngaha, and F. O. Ubah, Vitamin E and selenium in gentamicin nephrotoxicity, Hum. Exp. Toxicol., 9, 281-288 (1990).
25. S. E. Kays, W. A. Crowell, and M. A. Johnson, Iron supplementation increases gentamicin nephrotoxicity in rats, J. Nutr., 121, 1869-1875 (1991).
26. T. H. Ben Ismail, B. H. Ali, and A. A. Bashir, Influence of iron, deferoxamine and ascorbic acid on gentamicin-induced nephrotoxicity in rats, Gen. Pharmacol., 25, 1249-1252 (1994).
27. E. G. L. Bywaters and D. Beall, Crush injuries with impairment of renal function, Br. Med. J., 1, 427-432 (1941).
28. P. A. Gabow, W. D. Kaehny, and S. P. Kelleher, The spectrum of rhabdomyolysis, Medicine, 61, 141-152 (1982).
29. R. A. Grossman, R. W. Hamilton, B. M. Morse, A. S. Penn, and M. Goldberg, Nontraumatic rhabdomyolysis and acute renal failure, N. Engl. J. Med., 291, 807-811 (1974).
30. A. Koffler, R. M. Friedler, and S. G. Massry, Acute renal failure due to nontraumatic rhabdomyolysis, Ann. Intern. Med., 85, 23-28 (1976).
31. T. H. Hostetter, B. M. Wilkes, and B. M. Brenner, Renal circulatory and nephron function in experimental acute renal failure, in Acute Renal Failure (B. M. Brenner and J. M. Lazarus, eds.), W. B. Saunders, Philadelphia, 1983, pp. 99-115.
32. 2 generation by rat kidney in glycerol-induced renal failure, Am. J. Physiol., 257, F440-F445 (1989).
33. R. A. Zager, Rhabdomyolysis and myohemoglobinuric acute renal failure, Kidney Int., 49, 314-326 (1996).
34. R. A. Zager, Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria, Kidney Int., 49, 741-751 (1996).
35. A. K. Salahudeen, E. C. Clark, and K. A. Nath, Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo, J. Clin. Invest., 88, 1886-1893 (1991).
36. C. A. Bunton, Oxidation of α-diketones and α-keto-acids by hydrogen peroxide, Nature, 163, 444 (1949).
37. A. P. Halestrap, R. D. Scott, and A. P. Thomas, Mitochondrial pyruvate transport and its hormonal regulation, Int. J. Biochem., 11, 97-105 (1980).
38. H. Murer and G. Burckhardt, Membrane transport of anions across epithelia of mammalian small intestine and kidney proximal tubule, Rev. Physiol. Biochem. Pharmacol., 96, 1-51 (1983).
39. S. V. Shah and P. D. Walker, Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure, Am. J. Physiol., 255, F438-F443 (1988).
40. M. S. Paller, Hemoglobin-and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity, Am. J. Physiol., 255, F539-F544 (1988).
41. R. A. Zager, Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications, J. Clin. Invest., 90, 711-719 (1992).
42. S. Orrenius, A. Ellin, S. V. Jakobsson, H. Thor, D. L. Cinti, J. B. Schenkman, and R. W. Estabrook, The cytochrome P-450-containing monooxygenase system of rat kidney cortex microsomes, Drug Metab. Disp., I, 350-357 (1973).
43. G. K. Bysani, T. P. Kennedy, N. Ky, N. V. Rao, C. A. Blaze, and J. R. Hoidal, Role of cytochrome P-450 in reperfusion injury of the rabbit lung, J. Clin. Invest., 86, 1434-1441 (1990).
44. M. S. Paller and H. S. Jacob, Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney, Proc. Natl. Acad. Sci. USA, 91, 7002-7006 (1994).
45. R. Baliga, Z. Zhang, M. Baliga, and S. V. Shah, Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure, Kidney Int., 49, 362-369 (1996).
46. A. Meister, Selective modification of glutathione metabolism, Science, 220, 472-477 (1983).
47. A. Meister, New developments in glutathione metabolism and their potential application in therapy, Hepatology, 4, 739-742 (1984).
48. A. Meister, M. E. Anderson, and O. Hwang, Intracellular cysteine and glutathione delivery systems, J. Am. Coll. Nutr., 5, 137-151 (1986).
49. C. E. Olson, Glutathione modulates toxic oxygen metabolite injury of canine chief cell monolayers in primary culture, Am. J. Physiol., 254, G49-G56 (1988).
50. J. K. Dethmers and A. Meister, Glutathione export by human lymphoid cells: Depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation, Proc. Natl. Acad. Sci. USA, 78, 7492-7496 (1981).
51. B. A. Arrick, C. F. Nathan, O. W. Griffith, and Z. A. Cohn, Glutathione depletion sensitizes tumor cells to oxidative cytolysis, J. Biol. Chem., 257, 1231-1237 (1982).
52. S. P. Andreoli, C. P. Mallett, and J. M. Bergstein, Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury, J. Lab. Clin. Med., 108, 190-198 (1986).
53. J. H. Doroshow, G. Y. Locker, I. Ifrim, and C. E. Myers, Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine, J. Clin. Invest., 68, 1053-1064 (1981).
54. L. H. Lash, T. M. Hagen, and D. P. Jones, Exogenous glutathione protects intestinal epithelial cells from oxidative injury, Proc. Natl. Acad. Sci. USA, 83, 4641-4645 (1986).
55. M. S. Paller, J. R. Hoidal, and T. F. Ferris, Oxygen free radicals in ischemic acute renal failure in the rat, J. Clin. Invest., 74, 1156-1164 (1984).
56. R. E. Ratych and G. B. Bulkley, Free-radical-mediated postischemic reperfusion injury in the kidney, Free Radical Biol. Med., 2, 311-319 (1986).
57. M. S. Paller, Renal work, glutathione and susceptibility to free radical-mediated postischemic injury, Kidney Int., 33, 843-849 (1988).
58. R. A. Zager, Hypoperfusion-induced acute renal failure in the rat: An evaluation of oxidant tissue injury, Circ. Res., 62, 430-435 (1988).
59. J. Scaduto, V. H. Gattone, L. W. Grotyohann, J. Wertz, and L. F. Martin, Effect of an altered glutathione content on renal ischemic injury, Am. J. Physiol., 255, F911-F921 (1988).
60. S. R. Abul-Ezz, P. D. Walker, and S. V. Shah, Role of glutathione in an animal model of myoglobinuric acute renal failure, Proc. Natl. Acad. Sci. USA, 88, 9833-9837 (1991).
61. K. A. Nath, G. Balla, G. M. Vercellotti, J. Balla, H. S. Jacob, M. D. Levitt, and M. E. Rosenberg, Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat, J. Clin. Invest., 90, 267-270 (1992).
62. R. Stocker, Induction of haem oxygenase as a defense against oxidative stress, Free Radical Res. Commun., 9, 101-112 (1990).
63. S. M. Keyse and R. M. Tyrrell, Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide and sodium arsenite, Proc. Natl. Acad. Sci. USA, 86, 99-103 (1989).
64. L. A. Applegate, P. Luscher, and R. M. Tyrrell, Induction of heme oxygenase: A general response to oxidant stress in cultured mammalian cells, Cancer Res., 51, 974-978 (1991).
65. R. Baliga, Z. Zhang, M. Baliga, N. Ueda, and S. V. Shah, In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity, Kidney Int., 53, 394-401 (1998).
66. R. Baliga, Z. Zhang, M. Baliga, N. Ueda, and S. V. Shah, Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity, Kidney Int., 54, 1562-1569 (1998).
67. B. D. Kahan, Cyclosporine, N. Engl. J. Med., 321, 1725-1738 (1989).
68. O. F. P. Santos, M. A. Boim, R. Bregman, S. A. Draibe, E. J. G. Barros, E. Pirotzky, N. Schor, and P. Braquet, Effect of platelet-activating factor antagonist on cyclosporine nephrotoxicity: Glomerular hemodynamics evaluation, Transplantation, 47, 592-595 (1989).
69. M. S. Paller, Pathophysiologic mechanisms of acute renal failure, in Mechanisms of Injury in Renal Disease and Toxicity (R. S. Goldstein, ed.), CRC Press, Boca Raton, FL, 1994, pp. 3-13.
70. M. D. Burke and P. H. Whiting, The role of drug metabolism in cyclosporine A nephrotoxicity, Clin. Nephrol., 25, S111-S116 (1986).
71. A. Wolf, C. F. Trendelenburg, C. Diez-Fernandez, P. Prieto, and A. Cordier, Role of glutathione in cyclosporine A in vitro hepatotoxicity, Transplant. Proc., 26, 2912-2914 (1994).
72. A. Wolf, N. Clemann, W. Frieauff, B. Ryffel, and A. Cordier, Role of reactive oxygen formation in the cyclosporine-A-mediated impairment of renal functions, Transplant. Proc., 26, 2902-2907 (1994).
73. G. Inselmann, M. Blank, and K. Baumann, Cyclosporine A induced lipid peroxidation in microsomes and effect on active and passive glucose transport by brush border membrane vesicles of rat kidney, Res. Commun. Chem. Pathol. Pharmacol., 62, 207-220 (1988).
74. C. Wang and A. K. Salahudeen, Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E, Kidney Int., 47, 927-934 (1995).
75. P. D. Walker, C. Das, and S. V. Shah, Cyclosporin A induced lipid peroxidation in renal cortical mitochondria, Kidney Int., 29, 311 (1986).
76. R. J. Walker, V. A. Lazzaro, G. G. Duggin, J. S. Horvath, and D. J. Tiller, Evidence that alterations in renal metabolism and lipid peroxidation may contribute to cyclosporine nephrotoxicity, Transplantation, 50, 487-492 (1990).
77. F. Serino, J. Grevel, K. L. Napoli, B. D. Kahan, and H. W. Strobel, Generation of oxygen free radicals during the metabolism of cyclosporine A: A cause-effect relationship with metabolism inhibition, Mol. Cell. Biochem., 122, 101-112 (1993).
78. A. R. Gottschalk, L. H. Boise, C. B. Thompson, and J. Quintans, Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2, Proc. Natl. Acad. Sci. USA, 91, 7350-7354 (1994).
79. K. Kitagaki, S. Niwa, K. Hoshiko, H. Nagai, S. Hayashi, and T. Totsuka, Augmentation of apoptosis in bronchial exuded rat eosinophils by cyclosporin A, Biochem. Biophys. Res. Commun., 222, 71-77 (1996).
80. T. M. Buttke and P. A. Sandstrom, Oxidative stress as a mediator of apoptosis, Immunol. Today., 15, 7-10 (1994).
81. N. Ueda and S. V. Shah, Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells, J. Clin. Invest., 90, 2593-2597 (1992).
82. J. Hannemann and K. Baumann, Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers, Toxicology, 51, 119-132 (1988).
83. K. Sugihara and M. Gemba, Modification of cisplatin toxicity by antioxidants, Jpn. J. Pharmacol., 40, 353-355 (1986).
84. M. Gemba and N. Fukuishi, Amelioration by ascorbic acid of cisplatin-induced injury in cultured renal epithelial cells, Contrib. Nephrol., 95, 138-142 (1991).